SB
Syneron Bio
China · Biotech · Healthtech · AI
Develops intelligent platform-driven macrocyclic peptide drug discovery
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $150M | 5Y Capital — Role not disclosedAbu Dhabi Investment Authority — Role not disclosedAstraZeneca — Role not disclosedBiotech Development Fund — Role not disclosedBioTrack Capital — Role not disclosedCDH VGC — Role not disclosedDecheng Capital — Role not disclosedGL Ventures — Role not disclosedLAV — Role not disclosedLenovo Capital — Role not disclosedQiming Venture Partners — Role not disclosedSinovation Capital — Role not disclosedTrue Light Capital — Role not disclosed |